Correlation of magnetic resonance imaging findings with clinical staging in carcinoma of the cervix
DOI:
https://doi.org/10.18203/2349-2902.isj20261987Keywords:
Cervical carcinoma, MRI, FIGO staging, Diagnostic accuracy, Parametrial involvementAbstract
Background: Cervical carcinoma remains a significant health burden in developing countries, with accurate staging being critical for optimal management. Clinical International Federation of Gynecology and Obstetrics (FIGO) staging has limitations in assessing tumor extent and nodal involvement, whereas magnetic resonance imaging (MRI) offers improved visualization of local and regional disease. This study aimed to evaluate the correlation of MRI findings with clinical staging and assess its diagnostic accuracy in cervical carcinoma.
Methods: This hospital-based retrospective observational study was conducted in the Department of Radiology and Imaging, Combined Military Hospital (CMH), Dhaka, from October 2024 to September 2025. A total of 100 consecutive patients with histologically confirmed cervical carcinoma attending the Gynecology Oncology Department were included. Demographic, clinical, and MRI data were collected using a structured case record form.
Results: The majority of patients were aged 40-49 years (32%), married (85%), and postmenopausal (63%). Clinical FIGO staging showed stage IIIB (28%) and IIB (27%) as most frequent. MRI-based staging identified stage IIIB (31%) and IIB (25%) as most common. Concordance between clinical and MRI staging was 68%, with MRI assigning a higher stage in 65.6% of discordant cases. MRI demonstrated high diagnostic accuracy: parametrial involvement (sensitivity 91%, specificity 85%), pelvic sidewall invasion (94%, 96%), bladder/rectal involvement (87%, 98%), and tumor size >4 cm (92%, 90%).
Conclusions: MRI shows high concordance with clinical staging and superior detection of advanced disease, supporting its routine use for preoperative staging and treatment planning in cervical carcinoma.
References
World Health Organization. Cervical cancer: key facts. Geneva: WHO; 2024. Available at: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer. Accessed on 15 March 2026.
Ferlay J, Bray F, Pisani P, Parkin DM. Globocan 2002: Cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5, version 2.0. Lyon: IARC Press. 2004.
Eifel PJ, Berek JS, Thigpen JT. Cancer of cervix, vagina and vulva. In: DeVita VT Jr, Hellman S, Rosenberg SA, editors. Cancer: Principles and Practice of Oncology. Philadelphia: Lippincott. 1997;1433-75.
Narayan K, McKenzie AF, Hicks RJ, Fisher R, Bernshaw D, Bau S. Relation between FIGO stage, primary tumor volume and presence of lymph node metastases in cervical cancer patients referred for radiotherapy. Int J Gynecol Can. 2003;13(5):657-63.
Soutter WP, Hanoch J, D’Arcy T, Dina R, McIndoe GA, deSouza NM. Pretreatment tumor volume measurement on high-resolution magnetic resonance imaging as a predictor of survival in cervical cancer. BJOG. 2004;111(7):741-7.
Saksouk FA. Cervix, cancer, lymph node evaluation. eMedicine Radiology. 2009.
American Cancer Society. Early detection, diagnosis and staging of cervical cancer. American Cancer Society Guide. 2009.
Ho CM, Chien TY, Jeng CM, Tsang YM, Shih BY, Chang SC. Staging of cervical cancer: comparison between magnetic resonance imaging, computed tomography and pelvic examination under anesthesia. J Formos Med Assoc. 1992;91(10):982-90.
Lorenzen M, Braun J, Gehrckens A, Nicolas V. Value of MRI, CT and findings in staging of gynecologic malignancies. Aktuelle Radiol. 1998;8(6):266-72.
Hori M, Kim T, Onishi H. Uterine tumors: comparison of 3D versus 2D T2-weighted turbo spin-echo MR imaging at 3.0 T-initial experience. Radiology. 2011;258(1):154-63.
Pecorelli S, Zigliani L, Odicino F. Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet. 2009;105(2):107-8.
Bipat S, Glas AS, van der Velden J, Zwinderman AH, Bossuyt PM, Stoker J. Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review. Gynecol Oncol. 2003;91(1):59-66.
Kodaira T, Fuwa N, Toita T, Tachibana K. Clinical evaluation using magnetic resonance imaging for patients with stage III cervical carcinoma treated by radiation alone in multicenter analysis: its usefulness and limitations in clinical practice. Am J Clin Oncol. 2003;26(6):574-83.
Hricak H, Gatsonis C, Coakley FV. Early invasive cervical cancer: CT and MR imaging in preoperative evaluation-ACRIN/GOG comparative study of diagnostic performance and interobserver variability. Radiology. 2007;245(2):491-8.
Hancke K, Heilmann V, Straka P, Kreienberg R, Kurzeder C. Pretreatment staging of cervical cancer: is imaging better than palpation? Role of CT and MRI in preoperative staging of cervical cancer: single institution results for 255 patients. Ann Surg Oncol. 2008;15(10):2856-61.
Uddin AK, Sumon MA, Pervin S, Sharmin F. Cervical cancer in Bangladesh. South Asian J Cancer. 2023;12(01):036-8.
Nawapun S, Aphinives C, Srisitthiprapha W, Thamronganantasakul K, Temtanakitpaisan A. Correlation of clinical staging and MRI staging for cervical cancer. Egypt J Radiol Nuclear Med. 2021;52(1):162.
Balcacer P, Shergill A, Litkouhi B. MRI of cervical cancer with a surgical perspective: staging, prognostic implications and pitfalls. Abdominal Radiol. 2019;44(7):2557-71.
Otero-García MM, Mesa-Álvarez A, Nikolic O, Blanco-Lobato P, Basta-Nikolic M, de Llano- Ortega RM, et al. Role of MRI in staging and follow-up of endometrial and cervical cancer: pitfalls and mimickers. Insights Into Imaging. 2019;10(1):19.
Zhu Y, Shen B, Pei X, Liu H, Li G. CT, MRI and PET imaging features in cervical cancer staging and lymph node metastasis. Am J Translat Res. 2021;13(9):10536.
Luo L, Luo Q, Tang L. Diagnostic value and clinical significance of MRI and CT in detecting lymph node metastasis of early cervical cancer. Oncol Letters. 2020;19(1):700-6.
Karunya RJ, Tharani P, John S, Kumar RM, Das S. Role of functional magnetic resonance imaging derived parameters as imaging biomarkers and correlation with clinicopathological features in carcinoma of uterine cervix. J Clin Diagnost Res. 2017;11(8):XC06.
Park SH, Hahm MH, Bae BK, Chong GO, Jeong SY, Na S, et al. Magnetic resonance imaging features of tumor and lymph node to predict clinical outcome in node-positive cervical cancer: a retrospective analysis. Radiat Oncol. 2020;15(1):86.
Lindegaard JC, Petric P, Lindegaard AM, Tanderup K, Fokdal LU. Evaluation of a new prognostic tumor score in locally advanced cervical cancer integrating clinical examination and magnetic resonance imaging. Int J Radiat Oncol Biol Physics. 2020;106(4):754-63.
Knoth J, Pötter R, Jürgenliemk-Schulz IM, Haie-Meder C, Fokdal L, Sturdza A, et al. Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging-An analysis from the EMBRACE study. Gynecol Oncol. 2020;159(1):136-41.
Re GL, Cucinella G, Zaccaria G, Crapanzano A, Salerno S, Pinto A, Casto AL, Chiantera V. Role of MRI in the Assessment of Cervical Cancer. In Seminars in Ultrasound, CT and MRI. 2023;44(3):228-37.
Shih IL, Yen RF, Chen CA, Cheng WF, Chen BB, Chang YH, et al. PET/MRI in cervical cancer: associations between imaging biomarkers and tumor stage, disease progression and overall survival. J Magnetic Resonance Imaging. 2021;53(1):305-18.
Manganaro L, Lakhman Y, Bharwani N, Gui B, Gigli S, Vinci V, et al. Staging, recurrence and follow-up of uterine cervical cancer using MRI: Updated Guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018. Europ Radiol. 2021;31(10):7802-16.
Kim J, Cho Y, Kim N, Chung SY, Kim JW, Lee IJ, Kim YB. Magnetic resonance imaging-based validation of the 2018 FIGO staging system in patients treated with definitive radiotherapy for locally advanced cervix cancer. Gynecol Oncol. 2021;160(3):735-41.
Park KJ, Kim MH, Kim JK, Cho KS. Gastric-type adenocarcinoma of the uterine cervix: magnetic resonance imaging features, clinical outcomes and prognostic factors. Int J Gynecolog Cancer. 2018;28(6):1203-10.